Vitamin Shoppe misses 1Q profit forecasts

Lawrence Kim
May 25, 2017

In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 17.52% with $23.44 Million sitting short, betting on future declines. Parker Hannifin Corp now has $21.19B valuation. The share price is now down -39.68% for the past three months. The target implies a 8.51% spike from where the shares are now trading. Finally, Goldman Sachs Group Inc reduced their price target on shares of Vitamin Shoppe from $22.00 to $19.00 and set a "sell" rating for the company in a research note on Thursday, March 23rd. The stock was sold at an average price of $22.36, for a total transaction of $121,459.52. McKesson Corporation has 1 buy ratings, 12 holds and 0 sells even after the stock tumbled -28.17% from its high of $199.43 to a $31.49 billion market value through last close. Vitamin Shoppe had 17 analyst reports since August 6, 2015 according to SRatingsIntel. Morgan Stanley downgraded the shares of VSI in report on Thursday, November 3 to "Equal-Weight" rating.

11/05/2015 - Vitamin Shoppe, Inc had its " rating reiterated by analysts at Deutsche Bank.

The share price of Vitamin Shoppe, Inc (NYSE:VSI) was down -0.53% during the last trading session, with a day high of 19.00.

Shares of Vitamin Shoppe Inc (NYSE:VSI) opened at 11.99 on Tuesday.

10/27/2016 - Vitamin Shoppe, Inc was downgraded to " by analysts at JP Morgan.

As analysts monitor volatile markets in recent weeks they have updated their price targets on shares of Vitamin Shoppe, Inc (NYSE:VSI).

Shares of Vitamin Shoppe (NYSE:VSI) traded down 0.87% during midday trading on Friday, hitting $11.45.

Vitamin Shoppe, Inc. (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. Outstanding shares refer to a company's stock now held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Price to Earning P/E ratio and Forward P/E stand at 12.87 and 5.83 respectively. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats. VSI's SI was 4.40 million shares in May as released by FINRA. Morgan Stanley had a markedly different take on 17/01/2017, proposing that Vitamin Shoppe, now considered Underweight versus prior Equal-Weight rating. Nonetheless, from here on out, earnings per share forecasts for the current quarter are $0.52. Analysts are expecting EPS growth rates to be at -43.00% this quarter and EPS estimate for next year reflect a 9.26% growth rate. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the stock. Therefore 59% are positive. Liberum Capital downgraded Diageo plc (LON:DGE) rating on Monday, January 30. (NASDAQ:ACAD). Here's a quick look at what's moving shares of VSI, PCLN, and ACAD. So, investors often choose small-cap funds. Stifel Financial stated it has 0.2% in Parker-Hannifin Corp (NYSE:PH). Outstanding shares are shown on a company's balance sheet under the heading "Capital Stock". Arizona State Retirement has 33,024 shares. Finally, Gamco Investors INC. Bbva Compass National Bank & Trust Inc stated it has 27,544 shares. The Pittsburgh-based company reported earnings April 18 that sent shares up 24% that session. Following the sale, the director now directly owns 160,990 shares in the company, valued at approximately $3,580,417.60.

Receive Vitamin Shoppe, Inc News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe, Inc with's FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article